Company intelligence / Profile preview

Viroad Biotechnology

Shijiazhuang, Hebei, Chinalinkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

Viroad Biotechnology is a Chinese corporate investor founded in 2012 with its main office in Shijiazhuang. The firm invests primarily in health care and medical device sectors. There is no public information indicating that it develops its own therapeutic pipeline or clinical-stage assets. Its investment activity includes participation in funding rounds with other notable investors such as KfW, High-Tech Gründerfonds, and BC Brandenburg Capital. The fund typically invests $1–5 million per deal and has been involved with companies like GILUPI. Most investments are outside China, particularly Germany[1].

Industry: Investors

Partnerships

Co-investment partnerships with KfWHigh-Tech GründerfondsBC Brandenburg Capital

Beyond the preview

Go deeper on Viroad Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viroad Biotechnology.

Explore the full profile